|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.70 ILa | +1.83% |
|
+3.09% | - |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Medical Products | 25.96M | 30.51M | 29.14M | 34.77M | 25.66M | |||||
Total Assets | 33.89M | 40.02M | 41.93M | 41.96M | 33.62M | |||||
Interest Expense | -46K | -232K | -236K | -311K | -215K | |||||
Income Tax Expense | 257K | 499K | 288K | 414K | 291K | |||||
CAPEX | -304K | -659K | -457K | -274K | -35K | |||||
EBT | 1.14M | 2.68M | 875K | 797K | -2.86M | |||||
Gross Profit | 15.78M | 17.59M | 16.67M | 21.38M | 15.56M | |||||
D&A | 1.23M | 1.48M | 1.5M | 1.82M | 1.7M | |||||
Operating Income | 1.2M | 2.95M | 1.15M | 766K | -2.88M | |||||
Net Income | 884K | 2.18M | 587K | 383K | -3.15M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
USA | 13.65M | 17.51M | 15.51M | 16.33M | 13.42M | |||||
Other Countries | 5.31M | 6.48M | 7.79M | 5.42M | 6.27M | |||||
China | - | - | - | 11.6M | 5.37M | |||||
Israel | 193K | 276K | 103K | 1.42M | 594K | |||||
Asia | 6.81M | 6.24M | 5.74M | - | - |
- Stock Market
- Equities
- BIOV Stock
- Financials Bio-View Ltd
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















